Histological and molecular-biological analyses of poly(3-hydroxybutyrate) (PHB) patches for enhancement of bone regeneration

Annals of Anatomy

Volumn 199, Issue , 2015, Pages 36-42

  Gredes, Tomasz ^a   Gedrange, Tomasz ^a   Hinüber, Claudia ^a,b   Gelinsky, Michael ^c   Kunert Keil, Christiane ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biocompatibility; Bone healing; Osteoconduction; Rat cranium

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; CAVEOLIN 1; COLLAGEN TYPE 1; POLY(3 HYDROXYBUTYRIC ACID); SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN A; ADI1 PROTEIN, RAT; COLLAGEN TYPE I, ALPHA 1 CHAIN; DIOXYGENASE; HYDROXYBUTYRIC ACID; POLY-BETA-HYDROXYBUTYRATE; POLYESTER; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE CONDUCTION; BONE DEVELOPMENT; BONE REGENERATION; BONE TISSUE; BONE TRANSPLANTATION; CAPILLARY; CONNECTIVE TISSUE; CONTROLLED STUDY; EMBEDDING; FEMALE; FRACTURE HEALING; HISTOLOGY; IN VIVO STUDY; MALE; MOLECULAR BIOLOGY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKULL; SKULL DEFECT; TISSUE ENGINEERING; ANIMAL; BIOSYNTHESIS; BONE; CHORISTOMA; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; LEWIS RAT; METABOLISM; PATHOLOGY; SKELETAL MUSCLE; TISSUE SCAFFOLD;

ANIMALIA; RATTUS;

ANIMALS; BONE AND BONES; BONE REGENERATION; CAVEOLIN 1; CHORISTOMA; COLLAGEN TYPE I; CONNECTIVE TISSUE; DIOXYGENASES; FEMALE; HYDROXYBUTYRATES; MALE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; POLYESTERS; RATS; RATS, INBRED LEW; SKULL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929158659     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2014.04.003     Document Type: Article

References (47)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
2. Aho O.M., Lehenkari P., Ristiniemi J., Lehtonen S., Risteli J., Leskela H.V. The mechanism of action of induced membranes in bone repair. J. Bone Joint Surg. Am. 2013, 95:597-604.
3. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20:86-100.
4. Artsis M.I., Bonartsev A.P., Iordanskii A.L., Bonartseva G.A., Zaikov G.E. Biodegradation and medical application of microbial poly(3-hydroxybutyrate). Mol. Cryst. Liq. Cryst. 2010, 523:21-49.
5. Bernd H.E., Kunze C., Freier T., Sternberg K., Kramer S., Behrend D., Prall F., Donat M., Kramp B. Poly(3-hydroxybutyrate) (PHB) patches for covering anterior skull base defects - an animal study with minipigs. Acta Otolaryngol. 2009, 129:1010-1017.
6. Bonartsev A.P., Bonartseva G.A., Shaitan K.V., Kirpichnikov M.P. [Poly(3-hydroxybutyrate) and biopolymer systems on the basis of this polyester]. Biomed. Khim. 2011, 57:374-391.
7. Canullo L., Heinemann F., Gedrange T., Biffar R., Kunert-Keil C. Histological evaluation at different times after augmentation of extraction sites grafted with a magnesium-enriched hydroxyapatite: double-blinded randomized controlled trial. Clin. Oral Implants Res. 2013, 24:398-406.
8. Carlo Reis E.C., Batista Borges A.P., Fonseca C.C., Martinez Martinez M., Barros Eleoterio R., Oliveira Morato G., Oliveira P.M. Biocompatibility, osteointegration, osteoconduction, and biodegradation of a hydroxyapatit-polyhydroxybutyrate composite. Braz. Arch. Biol. Technol. 2010, 53:817-826.
9. Coombes A.G., Meikle M.C. Resorbable synthetic polymers as replacements for bone graft. Clin. Mater. 1994, 17:35-67.
10. Donahue H.J. Gap junctions and biophysical regulation of bone cell differentiation. Bone 2000, 26:417-422.
11. Doyle E., Tanner E.T., Bonfield W. In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials 1991, 12:841-847.
12. Frank P.G., Woodman S.E., Park D.S., Lisanti M.P. Caveolin, caveolae, and endothelial cell function. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1161-1168.
13. Gerstenfeld L.C., Chipman S.D., Kelly C.M., Hodgens K.J., Lee D.D., Landis W.J. Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts. J. Cell Biol. 1988, 106:979-989.
14. Glimcher M.J. Recent studies of the mineral phase in bone and its possible linkage to the organic matrix by protein-bound phosphate bonds. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1984, 304:479-508.
15. Gredes T., Heinemann F., Dominiak M., Mack H., Gedrange T., Spassov A., Klinke T., Kunert-Keil C. Bone substitution materials on the basis of BONITmatrix(R) up-regulate mRNA expression of IGF1 and Col1a1. Ann. Anat. 2011, 194:179-184.
16. Gredes T., Heinemann F., Dominiak M., Mack H., Gedrange T., Spassov A., Klinke T., Kunert-Keil C. Bone substitution materials on the basis of BONITmatrix(R) up-regulate mRNA expression of IGF1 and Col1a1. Ann. Anat. 2012, 194:179-184.
17. Gredes T., Kracht T., Gedrange T., Kunert-Keil C. Influence of BONITmatrix((R)) and OSSA NOVA on the expression of bone specific genes. Ann. Anat. 2012, 194:524-528.
18. Gredes T., Spassov A., Mai R., Mack H., Loster B.W., Mazurkiewicz-Janik M., Kubein-Meesenburg D., Fanghanel J., Gedrange T. Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants. J. Physiol. Pharmacol. 2009, 60(SUPPL. 3):77-81.
19. Gredes T., Wrobel-Kwiatkowska M., Dominiak M., Gedrange T., Kunert-Keil C. Osteogenic capacity of transgenic flax scaffolds. Biomed. Tech. (Berl.) 2012, 57:53-58.
20. Hada N., Okayasu M., Ito J., Nakayachi M., Hayashida C., Kaneda T., Uchida N., Muramatsu T., Koike C., Masuhara M., Sato T., Hakeda Y. Receptor activator of NF-kappaB ligand-dependent expression of caveolin-1 in osteoclast precursors, and high dependency of osteoclastogenesis on exogenous lipoprotein. Bone 2012, 50:226-236.
21. Heersche J.N., Reimers S.M., Wrana J.L., Waye M.M., Gupta A.K. Changes in expression of alpha 1 type 1 collagen and osteocalcin mRNA in osteoblasts and odontoblasts at different stages of maturity as shown by in situ hybridization. Proc. Finn. Dent. Soc. 1992, 88(SUPPL. 1):173-182.
22. Ishikawa K., Kawaguchi Y., Doi Y. Plasticization of bacterial polyester by the addition of acylglycerols and its enzymatic degradability. Kobunshi Ronbunshu 1991, 48:221-226.
23. Jensen S.S., Broggini N., Hjorting-Hansen E., Schenk R., Buser D. Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs. Clin. Oral. Implants Res. 2006, 17:237-243.
24. Kostopoulos L., Karring T. Guided bone regeneration in mandibular defects in rats using a bioresorbable polymer. Clin. Oral Implants Res. 1994, 5:66-74.
25. Kramp B., Bernd H.E., Schumacher W.A., Blynow M., Schmidt W., Kunze C., Behrend D., Schmitz K.P. [Poly-beta-hydroxybutyric acid (PHB) films and plates in defect covering of the osseus skull in a rabbit model]. Laryngorhinootologie 2002, 81:351-356.
26. Kunert-Keil C., Gredes T., Lucke S., Morgenstern S., Mielczarek A., Sporniak-Tutak K., Gedrange T., Spassov A. Caveolin-1, caveolin-3 and VEGF expression in the masticatory muscles of mdx mice. Folia Histochem. Cytobiol. 2011, 49:291-298.
27. Kunert-Keil C., Gredes T., Meyer A., Wrobel-Kwiatkowska M., Dominiak M., Gedrange T. The survival and proliferation of fibroblasts on biocomposites containing genetically modified flax fibers: an in vitro study. Ann. Anat. 2012, 194:513-517.
28. Kunert-Keil C., Scholz F., Gedrange T., Gredes T. Comparative study of biphasic calcium phosphate with beta-tricalcium phosphate in rat cranial defects - a molecular-biological and histological study. Ann. Anat. 2013, pii: S0940-9602(13)00168-4, [Epub ahead of print]. 10.1016/j.aanat.2013.12.001.
29. Kunze C., Edgar Bernd H., Androsch R., Nischan C., Freier T., Kramer S., Kramp B., Schmitz K.P. In vitro and in vivo studies on blends of isotactic and atactic poly (3-hydroxybutyrate) for development of a dura substitute material. Biomaterials 2006, 27:192-201.
30. Le Lay S., Blouin C.M., Hajduch E., Dugail I. Filling up adipocytes with lipids. Lessons from caveolin-1 deficiency. Biochim. Biophys. Acta 2009, 1791:514-518.
31. Lee S.Y. Bacterial polyhydroxyalkanoates. Biotechnol. Bioeng. 1996, 49:1-14.
32. Luklinska Z.B., Bonfield W. Morphology and ultrastructure of the interface between hydroxyapatite-polyhydroxybutyrate composite implant and bone. J. Mater. Sci. Mater. Med. 1997, 8:379-383.
33. Luklinska Z.B., Schluckwerder H. In vivo response to HA-polyhydroxybutyrate/polyhydroxyvalerate composite. J. Microsc. 2003, 211:121-129.
34. Mai R., Hagedorn M.G., Gelinsky M., Werner C., Turhani D., Spath H., Gedrange T., Lauer G. Ectopic bone formation in nude rats using human osteoblasts seeded poly(3)hydroxybutyrate embroidery and hydroxyapatite-collagen tapes constructs. J. Craniomaxillofac. Surg. 2006, 34(SUPPL. 2):101-109.
35. Mai R., Kunert-Keil C., Grafe A., Gedrange T., Lauer G., Dominiak M., Gredes T. Histological behaviour of zirconia implants: an experiment in rats. Ann. Anat. 2012, 194:561-566.
36. Ou G., Bao C., Liang X., Chao Y., Chen Z. [Histological study on the polyhydroxybutyric ester(PHB) membrane used for guided bone regeneration around titanium dental implants]. Hua Xi Kou Qiang Yi Xue Za Zhi 2000, 18:215-218.
37. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., Kennedy M.B., Pockwinse S., Lian J.B., Stein G.S. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 1990, 143:420-430.
38. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128:1496-1504.
39. Razak S.A., Sharif N., Rahman W. Biodegradable polymers and their bone applications: a review. IJBAS-IJENS 2012, 12:31-49.
40. Rentsch B., Hofmann A., Breier A., Rentsch C., Scharnweber D. Embroidered and surface modified polycaprolactone-co-lactide scaffolds as bone substitute: in vitro characterization. Ann. Biomed. Eng. 2009, 37:2118-2128.
41. Rogers G.F., Greene A.K. Autogenous bone graft: basic science and clinical implications. J. Craniofac. Surg. 2012, 23:323-327.
42. Rubin J., Schwartz Z., Boyan B.D., Fan X., Case N., Sen B., Drab M., Smith D., Aleman M., Wong K.L., Yao H., Jo H., Gross T.S. Caveolin-1 knockout mice have increased bone size and stiffness. J. Bone Miner. Res. 2007, 22:1408-1418.
43. Saito T., Tomita K., Juni K., Ooba K. In vivo and in vitro degradation of poly(3-hydroxybutyrate) in rat. Biomaterials 1991, 12:309-312.
44. Savenkova L., Gercberga Z., Nikolaeva V., Dzene A., Bibers I., Kalnin M. Mechanical properties and biodegradation characteristics of PHB-based films. Process Biochem. 2000, 35(6):573-579.
45. Sawada N., Taketani Y., Amizuka N., Ichikawa M., Ogawa C., Nomoto K., Nashiki K., Sato T., Arai H., Isshiki M., Segawa H., Yamamoto H., Miyamoto K., Takeda E. Caveolin-1 in extracellular matrix vesicles secreted from osteoblasts. Bone 2007, 41:52-58.
46. Stein G.S., Lian J.B., Gerstenfeld L.G., Shalhoub V., Aronow M., Owen T., Markose E. The onset and progression of osteoblast differentiation is functionally related to cellular proliferation. Connect. Tissue Res. 1989, 20:3-13.
47. Unverdorben M., Schatzlein H., Abt B., Wagner E., Vallbracht C. [Ten years of coronary stenting - current status and perspectives]. Dtsch. Med. Wochenschr. 1998, 123:1046-1051.